1. Home
  2. SIGI vs HAE Comparison

SIGI vs HAE Comparison

Compare SIGI & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Selective Insurance Group Inc.

SIGI

Selective Insurance Group Inc.

N/A

Current Price

$87.12

Market Cap

5.4B

Sector

Finance

ML Signal

N/A

HAE

Haemonetics Corporation

N/A

Current Price

$107.60

Market Cap

4.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIGI
HAE
Founded
1926
1971
Country
United States
United States
Employees
N/A
3009
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.8B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
SIGI
HAE
Price
$87.12
$107.60
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$85.80
$84.13
AVG Volume (30 Days)
276.1K
534.1K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.03%
N/A
EPS Growth
131.89
N/A
EPS
3.69
0.72
Revenue
$5,336,928,000.00
$910,373,000.00
Revenue This Year
$0.41
N/A
Revenue Next Year
$4.81
$5.23
P/E Ratio
$24.05
$147.96
Revenue Growth
9.78
N/A
52 Week Low
$72.78
$47.32
52 Week High
$100.40
$109.57

Technical Indicators

Market Signals
Indicator
SIGI
HAE
Relative Strength Index (RSI) 36.53 70.70
Support Level $81.10 $79.52
Resistance Level $91.48 $109.57
Average True Range (ATR) 1.69 2.51
MACD -0.21 -0.41
Stochastic Oscillator 16.17 92.31

Price Performance

Historical Comparison
SIGI
HAE

About SIGI Selective Insurance Group Inc.

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: